Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Palman (Moscow, Russian Federation), M. Poltavskaya (Moscow, Russian Federation), K. Sorokina (Moscow, Russian Federation). Acetazolamide is effective treatment of Cheyne–Stokes respiration in patients with chronic heart failure. 2501

Member's Comments

No comment yet.

Related content which might interest you: Cheyne Stokes respiration predicts early but not late mortality in patients with severe heart failure Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea Year: 2008 Influence of Cheyne Stokes respiration on baroreceptor sensitivity in patients with heart failure Source: Annual Congress 2005 - Control of breathing Year: 2005 Oxygen uptake efficiency slope in patients with chronic heart failure and coexisting respiratory disease Source: Eur Respir J 2006; 28: Suppl. 50, 639s Year: 2006 Effect of acute beta-blocker withholding on the ventilatory efficiency in patients with advanced chronic congestive heart failure Source: Annual Congress 2009 - Novel insights in exercise physiology from cells to humans Year: 2009 Acute effects of early mobility and respiratory therapy in hospitalised patients with chronic heart failure Source: Annual Congress 2009 - Respiratory physiotherapy assessment Year: 2009 Impulse oscillometry in patients with acute exacerbation COPD and severe chronic heart failure Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Respiratory compensation phase during exercise in chronic heart failure patients Source: Eur Respir J 2002; 20: Suppl. 38, 291s Year: 2002 Prevalence of Cheyne-Stokes respiration in congestive heart failure patients with modern medical treatment Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004 Association of impaired ventilatory efficiency with Chyene-Stokes respiration in patients with chronic heart failure Source: Eur Respir J 2002; 20: Suppl. 38, 292s Year: 2002 Impact of beta-blockers on sleep-disoredered breathing in chronic heart failure Source: Eur Respir J 2007; 30: Suppl. 51, 509s Year: 2007 Exercise heart rate recovery in chronic obstructive pulmonary disease patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010 Mortality in heart failure patients with nocturnal Cheyne-Stokes respiration receiving adaptive servoventilation (ASV) therapy Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004 Pulmonary diffusion capacity is not associated with severity of Cheyne-Stokes respiration in heart failure patients Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Effects of bi-level therapy in heart failure patients with cheyne-stokes respiration Source: Eur Respir J 2003; 22: Suppl. 45, 355s Year: 2003 Oxygen uptake efficiency slope in chronic heart failure and chronic obstructive pulmonary disease Source: Annual Congress 2008 - Exercise: system responses Year: 2008 Effects of bicameral pacing on exercise capacity and lung gas exchange in patients with severe chronic heart failure (CHF) Source: Eur Respir J 2002; 20: Suppl. 38, 291s Year: 2002